BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20006462)

  • 1. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
    Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse.
    Ueda M; Inaba M; Kumeda Y; Nagasaki T; Hiura Y; Tahara H; Onoda N; Ishikawa T; Nishizawa Y
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):657-62. PubMed ID: 16343100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis: elucidating diagnostic thresholds of peak systolic flow velocities in thyroid arteries for the discrimination of Graves' disease and destructive thyrotoxicosis.
    Li S; Ding Z; Li X; Fu M; Sang L; Yang M; Tang R; Gu T; Sang L
    Front Endocrinol (Lausanne); 2024; 15():1393126. PubMed ID: 38911037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
    Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
    Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between peak systolic velocity of the inferior thyroid artery and technetium-99m pertechnetate thyroid uptake in differentiating Graves' disease from thyroiditis.
    Malik SA; Choh NA; Misgar RA; Khan SH; Shah ZA; Rather TA; Shehjar F; Laway BA
    Arch Endocrinol Metab; 2019; 63(5):495-500. PubMed ID: 31482952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of colour Doppler sonography in patients with Graves' disease.
    Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
    West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study.
    Kurajoh M; Yamasaki A; Nagasaki T; Nagata Y; Yamada S; Imanishi Y; Emoto M; Takahashi K; Yamamoto K; Shintani A; Inaba M
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):232. PubMed ID: 31277608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?
    Zingrillo M; D'Aloiso L; Ghiggi MR; Di Cerbo A; Chiodini I; Torlontano M; Liuzzi A
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):201-6. PubMed ID: 8881453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diagnostic Utility of Color Doppler Ultrasonography, Tc-99m Pertechnetate Uptake, and TSH-Receptor Antibody for Differential Diagnosis of Graves' Disease and Silent Thyroiditis: A Comparative Study.
    Zuhur SS; Ozel A; Kuzu I; Erol RS; Ozcan ND; Basat O; Yenici FU; Altuntas Y
    Endocr Pract; 2014 Apr; 20(4):310-9. PubMed ID: 24246346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
    Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
    Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
    Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
    Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
    J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.